» Articles » PMID: 15260991

Single Cell Profiling of Potentiated Phospho-protein Networks in Cancer Cells

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2004 Jul 21
PMID 15260991
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

Altered growth factor responses in phospho-protein-driven signaling networks are crucial to cancer cell survival and pathology. Profiles of cancer cell signaling networks might therefore identify mechanisms by which such cells interpret environmental cues for continued growth. Using multiparameter flow cytometry, we monitored phospho-protein responses to environmental cues in acute myeloid leukemia at the single cell level. By exposing cancer cell signaling networks to potentiating inputs, rather than relying upon the basal levels of protein phosphorylation alone, we could discern unique cancer network profiles that correlated with genetics and disease outcome. Strikingly, individual cancers manifested multiple cell subsets with unique network profiles, reflecting cancer heterogeneity at the level of signaling response. The results revealed a dramatic remodeling of signaling networks in cancer cells. Thus, single cell measurements of phospho-protein responses reveal shifts in signaling potential of a phospho-protein network, allowing for categorizing of cell network phenotypes by multidimensional molecular profiles of signaling.

Citing Articles

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

Zhu J, Guerineau H, Lefebvre-Fortane A, Largeaud L, Lambert J, Rousselot P FEBS J. 2024; 292(1):115-128.

PMID: 39325663 PMC: 11705203. DOI: 10.1111/febs.17263.


Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex.

Arceneaux J, Brockman A, Khurana R, Chalkley M, Geben L, Krbanjevic A Cytometry B Clin Cytom. 2024; 108(1):35-54.

PMID: 38953209 PMC: 11693778. DOI: 10.1002/cyto.b.22194.


Predictability: A new distinguishing feature of cancer?.

Gofrit O, Aviv A PLoS One. 2024; 19(6):e0305181.

PMID: 38865416 PMC: 11168650. DOI: 10.1371/journal.pone.0305181.


Single Cell Profiling Distinguishes Leukemia-Selective Chemotypes.

Thirman H, Hayes M, Brown L, Porco Jr J, Irish J bioRxiv. 2024; .

PMID: 38826485 PMC: 11142275. DOI: 10.1101/2024.05.01.591362.


B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression.

Gambino S, Quaglia F, Galasso M, Cavallini C, Chignola R, Lovato O Sci Rep. 2024; 14(1):6595.

PMID: 38503806 PMC: 10951201. DOI: 10.1038/s41598-024-55728-9.